NEW YORK , May 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=151036&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=151041&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151042&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=151037&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=151038&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151039&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=151040&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151043&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

Itepekimab's inconsistent phase 3 results represent a setback for Regeneron Pharmaceuticals and Sanofi. The results do not support regulatory submissions and a 3-4 year approval delay, and lower peak sales potential looks like a best-case scenario for itepekimab. Regeneron faces a greater impact, as it is losing an important growth driver in the second half of the decade.

SANTA MONICA, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Super League Enterprise, Inc. (NASDAQ: SLE) (the “Company”), a leader in redefining how brands connect with consumers through the power of playable media, today announced that it has entered into definitive agreements in a registered direct offering with an institutional investor for the purchase and sale of approximately $670,000 of shares of Common Stock and Pre-funded Warrants.

Rivian Automotive is working with JPMorgan Chase on a potential high-yield bond sale, in part to refinance its upcoming debt, Bloomberg News reported on Friday, citing people familiar with the transaction.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming June 3, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) securities between August 8, 2024, to February 26, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON VIATRIS INC. (VTRS), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD.

CNBC's Deirdre Bosa joins 'Money Movers' to discuss Meta's Mark Zuckerberg and Palmer Luckey's reconciliation and the military connection that drove the reconnection.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this BWXT commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.

A.I. isn't just changing how people use search, but it's also changing how some litigators see Alphabet's (GOOGL) antitrust case. If the Big Tech giant is found to have a search monopoly, it will be forced to divest its Google Chrome browser.

SAN FRANCISCO--(BUSINESS WIRE)--Blend Labs Inc. (NYSE: BLND), a leading digital origination platform for banks, credit unions, and mortgage lenders, today announced that its management will participate at the following investor conference: William Blair 45th Annual Growth Stock Conference Chicago, IL Wednesday, June 4, 2025 Fireside Chat at 8:00 a.m. CT The conference fireside chat will be available via live audio webcast accessible on the Investors section of the Company's website at investor.

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / WHY: New York, N.Y., May 30, 2025.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151035&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

Shares of Trump Media & Technology Group Corp. DJT are trading higher Friday after company closed a $2.44 billion private placement with institutional investors.